Plasmacytoid dendritic cells: From specific surface markers to specific cellular functions

Human Immunology

Volumn 63, Issue 12, 2002, Pages 1133-1148

  Dzionek, Andrzej ^a   Inagaki, Yoshimasa ^b   Okawa, Katsuya ^b   Nagafune, Jun ^b   Röck, Jürgen ^a   Sohma, Yoshiaki ^b   Winkels, Gregor ^a   Zysk, Monika ^a   Yamaguchi, Yasunori ^b   Schmitz, Jürgen ^a  

^a MILTENYI BIOTEC GMBH   (Germany)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

BDCA 2; BDCA 4; Interferon type 1; Neuropilin 1; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; BDCA 2 ANTIGEN; BDCA 4 ANTIGEN; BETA INTERFERON; INTERLEUKIN 12; LECTIN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NEUROPILIN 1; PROTEIN P70; SEMAPHORIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TUMOR CELL; VIRUS IMMUNITY;

ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CYTOKINES; DENDRITIC CELLS; HUMANS; LECTINS, C-TYPE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; PLASMA CELLS; RECEPTORS, IMMUNOLOGIC;

EID: 0036925295     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00752-8     Document Type: Article

References (77)

1. Vollenweider R, Lennert K: Plasmacytoid T-cell clusters in non-specific lymphadenitis. Virchows Arch 44:1, 1983.
2. Facchetti F, de Wolf-Peeters C, Mason DY, Pulford KK, van den Oord JJ, Desmet VJ: Plasmacytoid T cells: Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol 133:15, 1988.
3. Perussia B, Fanning V, Trinchieri G: A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul 4:120, 1985.
4. Chehimi J, Starr SE, Kawashima H, Miller DS, Trinchieri G, Perussia B, Bandyopadhyay S: Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. Immunology 68:488, 1989.
5. Fitzgerald-Bocarsly P, Feldman M, Mendelsohn M, Curl S, Lopez C: Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J Leukoc Biol 43:323, 1988.
6. Feldman M, Fitzgerald-Bocarsly P: Sequential enrichment and immunocytochemical visualization of human interferon-alpha-producing cells. J Interferon Res 10:435, 1990.
7. Fitzgerald-Bocarsly P: Human natural interferon-alpha producing cells. Pharmacol Ther 60:39, 1993.
8. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835, 1999.
9. Svensson H, Johannisson A, Nikkila T, Alm GV, Cederblad B: The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry. Scand J Immunol 44:164, 1996.
10. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919, 1999.
11. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183, 1999.
12. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 192:1775, 2000.
13. Blom B, Ho S, Antonenko S, Liu YJ: Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192:1785, 2000.
14. Kadowaki N, Antonenko S, Liu YJ: Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded rna, respectively, stimulate CD11c(-) type 2 dendritic cell precursors and CD11c(+) dendritic cells to produce type I IFN. J Immunol 166:2291, 2001.
15. Ito T, Inaba M, Inaba K, Toki J, Sogo S, Iguchi T, Adachi Y, Yamaguchi Y, Amakawa R, Valladeau J, Saeland S, Fukuhara S, Ikehara S: A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 163:1409, 1999.
16. Kohrgruber N, Halanek N, Groger M, Winter D, Rappersberger K, Schmitt-Egenolf M, Stingl G, Maurer D: Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 163:3250, 1999.
17. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund Johansen F: Dendritic cell ontogeny: A human dendritic cell lineage of myeloid otigin. Proc Natl Acad Sci USA 94:12551, 1997.
18. O'Doherty U, Peng M, Gezelter S, Swiggard WJ, Betjes M, Bhardwaj N, Steinman RM: Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487, 1994.
19. Robinson SA, Patterson S, English N, Davies D, Knight SC, Reid CDL: Human peripheral blood contains two lineages of dendritic cells. Eur J Immunol 29:2769, 1999.
20. Liu YJ, Kanzler H, Soumelis V, Gilliet M: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2:585, 2001.
21. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037, 2000.
22. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J: BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194:1823, 2001.
23. Dzionek A, Fuchs A, Winkels G, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCA-3 and BDCA-4: Three novel markers for distinct subsets of dendritic cells in human peripheral blood. In Mason D, editor: Leucocyte Typing VII. Oxford, United Kingdom: Oxford University Press, 2002.
24. Strobl H, Scheinecker C, Riedl E, Csmarits B, Bello-Fernandez C, Pickl WF, Majdic O, Knapp W: Identification of CD68+1in- peripheral blood cells with dendritic precursor characteristics. J Immunol 161:740, 1998.
25. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N, Lee B: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 71:445, 2002.
26. Arce I, Roda-Navarro P, Montoya MC, Hernanz-Falcon P, Puig-Kroger A, Fernandez-Ruiz E: Molecular and genomic characterization of human DLEC, a novel member of the C-type lectin receptor gene family preferentially expressed on monocyte-derived dendritic cells. Eur J Immunol 31:2733, 2001.
27. Ariizumi K, Shen GL, Shikano S, Ritter R, Zukas P, Edelbaum D, Morita A, Takashima A: Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J Biol Chem 275:11957, 2000.
28. Fernandes MJ, Finnegan AA, Siracusa LD, Brenner C, Iscove NN, Calabretta B: Characterization of a novel receptor that maps near the natural killer gene complex: Demonstration of carbohydrate binding and expression in hematopoietic cells. Cancer Res 59:2709, 1999.
29. Fraser CC, Sharp JD, Wrighton N, Myers PS, Goodearl ADJ: Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses: In: WO 01/18016 A1, international patent application published under the patent cooperation treaty (PCT). United States: Millenium Pharmaceuticals, 2001.
30. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, Lanzavecchia A, Fransen J, Figdor CG, Piguet V, van Kooyk Y: The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168:2118, 2002.
31. Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, Pieters J: The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27:2417, 1997.
32. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM: The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151:673, 2000.
33. Stahl P, Schlesinger PH, Sigardson E, Rodman JS, Lee YC: Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: Characterization and evidence for receptor recycling. Cell 19:207, 1980.
34. Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, Mulder AA, van der Heiden AN, Scheidegger D, Oomen LC, Ottenhoff TH, Tulp A, Neefjes JJ, Koning F: Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 27:2426, 1997.
35. Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O: HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16:145, 2002.
36. Weis WI, Taylor ME, Drickamer K: The C-type lectin superfamily in the immune system. Immunol Rev 163:19, 1998.
37. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 408:740, 2000.
38. Batteux F, Palmer P, Daeron M, Weill B, Lebon P: FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Eur Cytokine Netw 10:509, 1999.
39. Ronnblom L, Alm GV: A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 194:F59, 2001.
40. Ronnblom L, Alm GV: An etiopathogenic role for the type I IFN system in SLE. Trends Immunol 22:427, 2001.
41. Bauer M, Redecke V, Ellwart JW, Scherer B, Kremer JP, Wagner H, Lipford GB: Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol 166:5000, 2001.
42. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, Ozaki Y, Tomizawa H, Akira S, Fukuhara S: Interferon-alpha and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 195:1507, 2002.
43. Gilliet M, Liu YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695, 2002.
44. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G: Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 31:3026, 2001.
45. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nature Rev Immunol 2:151, 2002.
46. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194:863, 2001.
47. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A: Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31:3388, 2001.
48. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres A, Hartmann G: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531, 2002.
49. Cousens LP, Orange JS, Su HC, Biron CA: Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 94:634, 1997.
50. McRae BL, Semnani RT, Hayes MP, van Seventer GA: Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160:4298, 1998.
51. Byrnes AA, Ma X, Cuomo P, Park K, Wahl L, Wolf SF, Zhou H, Trinchieri G, Karp CL: Type I interferons and IL-12: Convergence and cross-regulation among mediators of cellular immunity. Eur J Immunol 31:2026, 2001.
52. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F, Trinchieri G, Biron CA: Interferon alpha/beta and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195:517, 2002.
53. Cella M, Facchetti F, Lanzavecchia A, Colonna M: Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1:305, 2000.
54. Kadowaki N, Antonenko S, Lau JY, Liu YJ: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219, 2000.
55. Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 178:1655, 1993.
56. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547, 1993.
57. Eloranta ML, Alm GV: Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand J Immunol 49:391, 1999.
58. Bowen MB, Butch AW, Parvin CA, Levine A, Nahm MH: Germinal center T cells are distinct helper-inducer T cells. Hum Immunol 31:67, 1991.
59. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Forster R: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192:1545, 2000.
60. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD: Neuropilin is a semaphorin III receptor. Cell 90:753, 1997.
61. He Z, Tessier-Lavigne M: Neuropilin is a receptor for the axonal chemorepellent Semaphorin III, Cell 90:739, 1997.
62. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735, 1998.
63. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki Ji J, Hirota S, Kitamura Y, Kitsukawa T, Fujisawa H, Klagsbrun M, Hori M: Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A 99:3657, 2002.
64. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, Hermine O, Romeo PH: A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 3:477, 2002.
65. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101, 1997.
66. Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M: VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding. J Cell Biochem 85:357, 2002.
67. Ytterberg SR, Schnitzer TJ: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 25:401, 1982.
68. Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L: Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 115:196, 1999.
69. Vallin H, Perers A, Alm GV, Ronnblom L: Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 163:6306, 1999.
70. Bave U, Alm GV, Ronnblom L: The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol 165:3519, 2000.
71. Cederblad B, Blomberg S, Vallin H, Peters A, Alm GV, Ronnblom L: Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmun 11:465, 1998.
72. Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L: Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10:484, 2001.
73. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL: Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 159:237, 2001.
74. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Ronnblom L: Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664, 2000.
75. Kalkner KM, Ronnblom L, Karlsson Parra AK, Bengtsson M, Olsson Y, Oberg K: Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon. Qjm 91:393, 1998.
76. Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178, 1991.
77. Ronnblom LE, Alm GV, Oberg KE: Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 227:207, 1990.